BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20934416)

  • 1. Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin.
    Winiarska K; Grabowski M; Rogacki MK
    Chem Biol Interact; 2011 Jan; 189(1-2):119-26. PubMed ID: 20934416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK1/2 pathway is involved in renal gluconeogenesis inhibition under conditions of lowered NADPH oxidase activity.
    Winiarska K; Jarzyna R; Dzik JM; Jagielski AK; Grabowski M; Nowosielska A; Focht D; Sierakowski B
    Free Radic Biol Med; 2015 Apr; 81():13-21. PubMed ID: 25601753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits.
    Winiarska K; Szymanski K; Gorniak P; Dudziak M; Bryla J
    Biochimie; 2009 Feb; 91(2):261-70. PubMed ID: 18957317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: a comparison with melatonin.
    Winiarska K; Focht D; Sierakowski B; Lewandowski K; Orlowska M; Usarek M
    Chem Biol Interact; 2014 Jul; 218():12-9. PubMed ID: 24797087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of selenium compounds on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies.
    Kiersztan A; Lukasinska I; Baranska A; Lebiedzinska M; Nagalski A; Derlacz RA; Bryla J
    J Inorg Biochem; 2007 Mar; 101(3):493-505. PubMed ID: 17222910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction.
    Hayashi T; Juliet PA; Kano-Hayashi H; Tsunekawa T; Dingqunfang D; Sumi D; Matsui-Hirai H; Fukatsu A; Iguchi A
    Diabetes Obes Metab; 2005 Jul; 7(4):334-43. PubMed ID: 15955119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of selegiline on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies.
    Drozak J; Kozlowski M; Doroszewska R; Pera L; Derlacz R; Jarzyna R; Bryla J
    Chem Biol Interact; 2007 Dec; 170(3):162-76. PubMed ID: 17767924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits.
    Winiarska K; Malinska D; Szymanski K; Dudziak M; Bryla J
    Biochimie; 2008 Mar; 90(3):450-9. PubMed ID: 18157951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.
    Taye A; Saad AH; Kumar AH; Morawietz H
    Eur J Pharmacol; 2010 Feb; 627(1-3):42-8. PubMed ID: 19878672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits.
    Chan EC; Datla SR; Dilley R; Hickey H; Drummond GR; Dusting GJ
    Cardiovasc Res; 2007 Sep; 75(4):710-8. PubMed ID: 17659266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow increases superoxide production by NADPH oxidase via activation of Na-K-2Cl cotransport and mechanical stress in thick ascending limbs.
    Hong NJ; Garvin JL
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F993-8. PubMed ID: 17132867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress.
    Riganti C; Costamagna C; Bosia A; Ghigo D
    Toxicol Appl Pharmacol; 2006 May; 212(3):179-87. PubMed ID: 16120450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages.
    Matthiesen S; Lindemann D; Warnken M; Juergens UR; Racké K
    Eur J Pharmacol; 2008 Jan; 579(1-3):403-10. PubMed ID: 18001708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of superoxide in modulating the renal effects of angiotensin II.
    López B; Salom MG; Arregui B; Valero F; Fenoy FJ
    Hypertension; 2003 Dec; 42(6):1150-6. PubMed ID: 14597645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent transition from H(2)O(2)-extracellular signal-regulated kinase- to O(2)-nitric oxide-dependent mechanisms in the stimulatory effect of leptin on renal Na+/K+/-ATPase in the rat.
    Marciniak A; Borkowska E; Kedra A; Rychlik M; Beltowski J
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1216-24. PubMed ID: 17184504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of high pacing-induced ANP secretion by antioxidants in isolated rat atria.
    Gao S; Yuan K; Shah A; Kim JS; Park WH; Kim SH
    Peptides; 2011 Dec; 32(12):2467-73. PubMed ID: 22063193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
    Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.